BeOne Medicines Ltd.ONC
Close of Friday, October 23, 2026 · BeOne Medicines Ltd. is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$377.66
vs its Pivot
+16.5%
OnlyAlpha Score
60
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| +4.9% | +24.3% | +20.4% | +31.1% | +1.0% |
No dividend in the last 12 months.
Who runs and owns it
Run by John Oyler (co-founder, CEO), one of the Forbes billionaires.
In these funds
IBB · 2.17%
Big investors that own it (latest 13F)
| Baker Bros. Advisors Julian and Felix Baker | 12.6% of holdings |
| Temasek Singapore state investor | 0.7% of holdings |
| Citadel Ken Griffin | 0.2% of holdings |
Suppliers, customers and partners
Partners and deals
| Amgen | Asia-Pacific commercial partner |
From the companies' own annual reports filed with the SEC.
Healthcare · Biotech
Get ONC in your free daily emailAfter every close: whether ONC is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track ONC free → Full Stock check
Track ONC free → Full Stock check